Hoshiko K et al. |
Histamine(H1) antagonists and airway hyperreactivity in the guinea-pig. |
1991 |
Agents Actions Suppl. |
pmid:1686527
|
Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Muirhead EE |
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. |
1987 |
Agents Actions Suppl. |
pmid:3324720
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
|
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. |
1987 |
Agents Actions Suppl. |
pmid:3478993
|
Farr RS et al. |
Platelet abnormalities in asthma--do they exist in humans? |
1987 |
Agents Actions Suppl. |
pmid:3478994
|
Barnes PJ |
New concepts in the pathogenesis of bronchial hyperresponsiveness. |
1987 |
Agents Actions Suppl. |
pmid:3314413
|
Subissi A and Criscuoli M |
Effects of LG 30435 on different platelet activating factor-induced responses. |
1988 |
Agents Actions Suppl. |
pmid:3262990
|
Heuer H and Casals-Stenzel J |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. |
1988 |
Agents Actions Suppl. |
pmid:3262991
|
Anderson GP and Fennessy MR |
Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. |
1988 |
Agents Actions Suppl. |
pmid:3140616
|
Schrör K and Felsch A |
Ramiprilat prevents PAF-induced myocellular and endothelial injury in a neutrophil-perfused heart preparation. |
1992 |
Agents Actions Suppl. |
pmid:1334351
|
Stenzel H et al. |
Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. |
1987 |
Agents Actions Suppl. |
pmid:2823582
|
O'Flaherty JT and Wykle RL |
Metabolic origin and fate of platelet-activating factor. |
1987 |
Agents Actions Suppl. |
pmid:2823583
|
Bertrand C et al. |
Selective implication of thromboxane A2 and PAF-acether in two guinea pig anaphylactic models. |
1990 |
Agents Actions Suppl. |
pmid:2080755
|
Tsunoda H et al. |
Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses. |
1990 |
Agents Actions Suppl. |
pmid:2080757
|
Sakuma Y et al. |
Effects of a novel PAF antagonist, E6123, on passive anaphylaxis. |
1990 |
Agents Actions Suppl. |
pmid:2080758
|
Soloviev A and Braquet P |
The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: possible explanation for hypoxic coronary spasm development. |
1995 |
Agents Actions Suppl. |
pmid:7717190
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Hartung HP et al. |
Stimulation of the oxidative burst in macrophages with platelet activating factor (PAF-acether). |
1982 |
Agents Actions Suppl. |
pmid:6960648
|